Health Care: Drugs

Amgen Inc (AMGN: NASDAQ)

$141.14 -3.9 | -2.69%
02/08/16 - 11:56 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 21.66B 20.06B 18.68B 17.27B
Cost of Sales 4.23B 2.33B 2.06B 2.12B
Gross Operating Profit 17.43B 17.73B 16.62B 15.14B
Selling, General, and Administrative Expenses 4.85B 4.70B 5.18B 4.80B
Research & Development 4.07B 4.30B 4.08B 3.38B
Operating Income before D & A (EBITDA) 8.52B 8.74B 7.35B 6.96B
Depreciation & Amortization n.a. 2.09B 1.29B 1.09B
Interest Income 603.00M 0.00 0.00 485.00M
Other Income - Net 0.00 -454.00M -196.00M -295.00M
Special Income / Charges -49.00M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 9.07B 6.19B 5.87B 6.06B
Interest Expense 1.09B 606.00M 602.00M 1.05B
Pre-Tax Income 7.98B 5.58B 5.26B 5.01B
Income Taxes 1.04B 427.00M 184.00M 664.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 6.94B 5.16B 5.08B 4.34B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 6.94B 5.16B 5.08B 4.34B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 6.94B 5.16B 5.08B 4.34B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.99B 5.16B 5.08B 4.34B
Preferred Dividends
Net Income Available To Common 0.00 5.16B 5.08B 4.34B
Basic EPS from Continuing Ops. 9.15 6.80 6.75 5.61
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 9.15 6.80 6.75 5.61
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 9.15 6.80 6.75 5.61
Basic Normalized Net Income/Share 9.22 6.80 6.75 5.61
EPS fr Continuing Ops. 9.06 6.70 6.64 5.52
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 9.06 6.70 6.64 5.52
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 9.06 6.70 6.64 5.52
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
9.12 6.70 6.64 5.52
Dividends Paid per Share 3.16 2.44 1.88 1.44

Portfolios with AMGN

Latest AMGN Headlines from TheStreet

More Financial News for AMGN

Press Releases for AMGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter